Several people in Austria were treated in a hospital after using what government officials believe to be counterfeit Ozempic, underscoring worries across parts of Europe that fake versions of the diabetes drug may be circulating.
Ozempic began trending this year as celebrities, TikTok influencers and others described using it to quickly lose weight.
It was first approved by the Food and Drug Administration in 2017 to treat diabetes.
A similar drug called Wegovy, which contains a higher dose of Ozempic’s active ingredient, semaglutide, was approved in 2021.
The patients treated in Austria reported serious side effects like hypoglycemia and seizures, indications that the product most likely contained insulin instead of semaglutide, officials said.
Persons:
underscoring, Ozempic, TikTok influencers, semaglutide
Organizations:
Food and Drug Administration
Locations:
Austria, Europe